TOPICS
Video Marketing for Biotech & Pharma
DIRECT ANSWER
Video marketing is the strategic use of video content to attract, engage, and convert audiences at every stage of the buyer journey. It spans short-form social videos, long-form educational content, product demos, customer testimonials, live streams, and ads—distributed across platforms where target audiences already spend time. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What video marketing means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
Video Formats and When to Use Each
Short-form video (under 60 seconds) dominates discovery on TikTok, Instagram Reels, and YouTube Shorts—ideal for brand awareness, trend participation, and top-of-funnel reach. Long-form video (tutorials, webinars, case studies, interviews) serves mid-funnel buyers researching solutions; it performs best on YouTube and gated resource centers. Product demos and explainer videos accelerate bottom-of-funnel decisions by showing rather than telling.
Video ads—pre-roll, mid-roll, connected TV, and in-feed—combine the persuasive power of video with paid targeting precision. Even a single well-produced hero video can be repurposed across multiple formats and placements.
Running video marketing for Biotech & Pharma with CoMo
CoMo's agents apply video marketing across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Video Marketing for Biotech & Pharma — common questions
How long should a marketing video be?
Length should match context and objective. Social discovery videos perform best under 60 seconds; many top-performing short-form videos are 15–30 seconds. Explainer videos and demos can run 2–5 minutes. Webinar recordings and documentary-style content can extend to 30–60 minutes for audiences already engaged with your brand.
How does video marketing differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.